Cargando…

Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer

BACKGROUND: Monocarboxylate transporters (MCTs) are transmembrane proteins involved in the transport of monocarboxylates across the plasma membrane, which appear to play an important role in solid tumours, however the role of MCTs in prostate cancer is largely unknown. The aim of the present work wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pértega-Gomes, Nelma, Vizcaíno, José R, Miranda-Gonçalves, Vera, Pinheiro, Céline, Silva, Joana, Pereira, Helena, Monteiro, Pedro, Henrique, Rui M, Reis, Rui M, Lopes, Carlos, Baltazar, Fátima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3157459/ https://www.ncbi.nlm.nih.gov/pubmed/21787388 http://dx.doi.org/10.1186/1471-2407-11-312

Ejemplares similares

Clinical impact of the metabolic phenotype of prostate cancer: role of monocarboxylate transporters (MCTs)
por: Pértega-Gomes, Nelma, et al.
Publicado: (2013)

Expression of Monocarboxylate Transporters 1, 2, and 4 in Human Tumours and Their Association with CD147 and CD44
por: Pinheiro, Céline, et al.
Publicado: (2010)

Localization of MCT2 at peroxisomes is associated with malignant transformation in prostate cancer
por: Valença, Isabel, et al.
Publicado: (2015)

Monocarboxylate Transporters 1 and 4 Are Associated with CD147 in Cervical Carcinoma
por: Pinheiro, Céline, et al.
Publicado: (2009)

Monocarboxylate Transporter 4 (MCT4) Overexpression Is Correlated with Poor Prognosis of Osteosarcoma
por: Liu, Yannan, et al.
Publicado: (2019)

Characterization of monocarboxylate transporters (MCTs) expression in soft tissue sarcomas: distinct prognostic impact of MCT1 sub-cellular localization
por: Pinheiro, Céline, et al.
Publicado: (2014)

MCT1 Is a New Prognostic Biomarker and Its Therapeutic Inhibition Boosts Response to Temozolomide in Human Glioblastoma
por: Miranda-Gonçalves, Vera, et al.
Publicado: (2021)

Role of Human Monocarboxylate Transporter 1 (hMCT1) and 4 (hMCT4) in Tumor Cells and the Tumor Microenvironment
por: Liu, Tian, et al.
Publicado: (2023)

Inhibition of monocarboxylate transporters (MCT) 1 and 4 reduces exercise capacity in mice
por: Kitaoka, Yu, et al.
Publicado: (2022)

Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
por: Porst, Theresa, et al.
Publicado: (2021)

High expression of monocarboxylate transporter 4 (MCT 4), but not MCT 1, predicts poor prognosis in patients with non-small cell lung cancer
por: Tong, Ying-Hui, et al.
Publicado: (2021)

Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival
por: Eilertsen, Marte, et al.
Publicado: (2014)

Monocarboxylate Transporter 1 (MCT1) in Liver Pathology
por: Droździk, Marek, et al.
Publicado: (2020)

Crucial Residue Involved in L-Lactate Recognition by Human Monocarboxylate Transporter 4 (hMCT4)
por: Sasaki, Shotaro, et al.
Publicado: (2013)

Monocarboxylate Transporter 4 (MCT4) Knockout Mice Have Attenuated 4NQO Induced Carcinogenesis; A Role for MCT4 in Driving Oral Squamous Cell Cancer
por: Bisetto, Sara, et al.
Publicado: (2018)

Lactate Transporters in the Context of Prostate Cancer Metabolism: What Do We Know?
por: Pértega-Gomes, Nelma, et al.
Publicado: (2014)

Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas
por: Miranda-Gonçalves, Vera, et al.
Publicado: (2016)

Monocarboxylate Transporter 1 (MCT1) Mediates Succinate Export in the Retina
por: Bisbach, Celia M., et al.
Publicado: (2022)

A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy
por: Pertega‐Gomes, Nelma, et al.
Publicado: (2015)

A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer
por: Pértega-Gomes, Nelma, et al.
Publicado: (2014)

Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer
por: Latif, Ayşe, et al.
Publicado: (2017)

MCT1 in Invasive Ductal Carcinoma: Monocarboxylate Metabolism and Aggressive Breast Cancer
por: Johnson, Jennifer M., et al.
Publicado: (2017)

Role and Clinical Significance of Monocarboxylate Transporter 8 (MCT8) During Pregnancy
por: Thomas, Jinsu, et al.
Publicado: (2023)

Comprehensive Analysis of Monocarboxylate Transporter 4 (MCT4) expression in breast cancer prognosis and immune infiltration via integrated bioinformatics analysis
por: Yuan, Chen, et al.
Publicado: (2021)

Evaluation of MCT1, MCT4 and CD147 Genes in Peripheral Blood Cells of Breast Cancer Patients and Their Potential Use as Diagnostic and Prognostic Markers
por: Luz, Maria Cláudia de B., et al.
Publicado: (2017)

Regulation of Acetate Utilization by Monocarboxylate Transporter 1 (MCT1) in Hepatocellular Carcinoma (HCC)
por: Jeon, Jeong Yong, et al.
Publicado: (2018)

The Hepatic Monocarboxylate Transporter 1 (MCT1) Contributes to the Regulation of Food Anticipation in Mice
por: Martini, Tomaz, et al.
Publicado: (2021)

Prognostic Value of Monocarboxylate Transporter 1 Overexpression in Cancer: A Systematic Review
por: Silva, Ana, et al.
Publicado: (2023)

Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
por: Bovenzi, Cory D., et al.
Publicado: (2015)

Butyric acid increases transepithelial transport of ferulic acid through upregulation of the monocarboxylate transporters SLC16A1 (MCT1) and SLC16A3 (MCT4)
por: Ziegler, Kerstin, et al.
Publicado: (2016)

The clinicopathological significance of monocarboxylate transporters in testicular germ cell tumors
por: Silva, Eduardo C.A., et al.
Publicado: (2018)

Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination
por: Lee, Jae Young, et al.
Publicado: (2017)

MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma
por: Fisel, Pascale, et al.
Publicado: (2015)

Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer
por: Pertega-Gomes, Nelma, et al.
Publicado: (2015)

The inhibition of monocarboxylate transporter 2 (MCT2) by AR-C155858 is modulated by the associated ancillary protein
por: Ovens, Matthew J., et al.
Publicado: (2010)

The Neuroplastin Adhesion Molecules Are Accessory Proteins That Chaperone the Monocarboxylate Transporter MCT2 to the Neuronal Cell Surface
por: Wilson, Marieangela C., et al.
Publicado: (2013)

Monocarboxylate transporter-1 (MCT1) protein expression in head and neck cancer affects clinical outcome
por: Leu, Martin, et al.
Publicado: (2021)

Brachyury as a potential modulator of androgen receptor activity and a key player in therapy resistance in prostate cancer
por: Pinto, Filipe, et al.
Publicado: (2016)

AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7–10
por: Ovens, Matthew J., et al.
Publicado: (2010)

A Holistic Evolutionary and 3D Pharmacophore Modelling Study Provides Insights into the Metabolism, Function, and Substrate Selectivity of the Human Monocarboxylate Transporter 4 (hMCT4)
por: Papakonstantinou, Eleni, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_02n1d7ttstqiba1hp8ndfs8ka6